Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_assertion type Assertion NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_head.
- NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_assertion description "[Incorporation of panels of prostate cancer risk SNPs into clinical practice offers potential to provide improvements in patient selection for prostate cancer screening; PSA interpretation (e.g. by correcting for the presence of SNPs that influence PSA expression levels; decision for biopsy (using prostate cancer risk SNPs); and possibly the decision for treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_provenance.
- NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_assertion evidence source_evidence_literature NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_provenance.
- NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_assertion SIO_000772 25405931 NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_provenance.
- NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_assertion wasDerivedFrom befree-2016 NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_provenance.
- NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_assertion wasGeneratedBy ECO_0000203 NP1238307.RA8Z12hyTqcsw5Y4vmlLRM_Nwu_fc5vp6N4gvhIkE3ZXM130_provenance.